Hepcinat 400 mg Tablet - Uses, Dosage, Side Effects, Price ...

Discription

Hepcinat 400 mg Tablet is an antiviral drug used to treat chronic hepatitis C infection. It is also used in patients with liver cancer and hepatitis C infection planning to undergo liver transplantation. This drug minimizes the chance of infection recurring after transplantation. Hepcinat 400 mg Tablet is not recommended for patients with a known history of hepatitis B infection.

What is the purpose of Hepcinat (Sofosbuvir)?

Hepcinat, considered to be a real breakthrough in the treatment of chronic hepatitis C, has recently emerged in the world pharmaceutical market. Sofosbuvir can now replace interferon, which is widely known for causing certain adverse reactions and has many contraindications. Currently, it has been approved for use in 120 countries around the world. Sofosbuvir can be used to treat patients with cirrhosis and HIV.

Side Effects

Major & minor side effects for Hepcinat 400 mg Tablet

• chill
• Mouth sores or leukoplakia
• lumbago
• headache
• rash
• irritability
• diarrhea
• nausea
• Loss of appetite
• Muscle pain and cramps

Uses of Hepcinat 400 mg tablets

What are the rules?

• Chronic hepatitis C

          Hepcinat 400 mg tablets are used to treat chronic hepatitis C virus infection to prevent the                   growth and spread of the virus in the body.

• Hepatocellular carcinoma and liver transplantation

          The drug is used to plan liver transplantation to prevent patients with hepatocellular carcinoma            and hepatitis C from recurring infection.


Dosage and administration

Each film-coated tablet of Hepcinat (Sofosbuvir) contains 400 mg of the main ingredient. The dosage table must be individualized by the physician responsible for the treatment and will vary according to the genotype of the virus being treated. Adult patients are usually instructed by their doctor to take 1 tablet a day, either with or without food.

The doctor may order patients with GT1 or GT4 (genotype 1 or 4) to take it with ribavirin and pegylated interferon alpha for 12 weeks. In contrast, GT2 (genotype 2) usually requires 12 weeks of treatment and is taken with ribavirin. GT3 (genotype 3) requires 24 weeks of treatment with ribavirin. Patients can only be taken according to the instructions provided by the physician responsible for treatment

Precaution

Patients receiving Hepcinat medication for Hepatitis C need to see a doctor or hospital regularly so that a routine blood test can be performed. The frequency of these tests will be determined by your doctor.

Unborn babies associated with this drug are at risk of birth defects or other serious injuries, and pregnant women should never take them. During treatment and for at least 6 months after treatment, at least 2 effective non-hormonal barrier methods of contraception should always be used.

If you want to get more information  Click here